UnitedHealth Group (UNH) – Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for UnitedHealth Group (NYSE: UNH):

• 10/27/2026 – UnitedHealth Group had its price target lowered by Wells Fargo & Company from $526.00 to $487.00. They now have an “overweight” rating on the stock.
• 10/27/2026 – UnitedHealth Group had its price target raised by Morgan Stanley from $529.00 to $531.00. They now have an “overweight” rating on the stock.
• 10/22/2026 – UnitedHealth Group had its price target raised by Mizuho from $493.00 to $500.00. They now have an “outperform” rating on the stock.
• 10/20/2026 – UnitedHealth Group had its price target raised by Royal Bank Of Canada from $478.00 to $498.00. They now have an “outperform” rating on the stock.
• 10/16/2026 – UnitedHealth Group was given a new $500.00 price target by HC Wainwright.
• 10/16/2026 – UnitedHealth Group was given a new $500.00 price target by Stephens.
• 10/16/2026 – UnitedHealth Group had its price target raised by JPMorgan Chase & Co. from $516.00 to $524.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – UnitedHealth Group had its “outperform” rating reaffirmed by Raymond James Financial. They now have a $450.00 price target on the stock.
• 10/15/2026 – UnitedHealth Group had its “hold” rating reaffirmed by TD Cowen. They now have a $402.00 price target on the stock.
• 10/14/2026 – UnitedHealth Group had its “overweight” rating reaffirmed by KeyCorp.
• 10/14/2026 – UnitedHealth Group had its price target lowered by Sanford C. Bernstein from $512.00 to $500.00. They now have an “outperform” rating on the stock.
• 10/14/2026 – UnitedHealth Group had its price target raised by Piper Sandler from $502.00 to $504.00. They now have an “overweight” rating on the stock.
• 10/14/2026 – UnitedHealth Group had its price target lowered by Barclays from $441.00 to $440.00. They now have an “overweight” rating on the stock.
• 10/14/2026 – UnitedHealth Group had its price target lowered by Robert W. Baird from $453.00 to $427.00. They now have a “neutral” rating on the stock.
• 10/13/2026 – UnitedHealth Group had its “outperform” rating reaffirmed by UBS Group.
• 10/9/2026 – UnitedHealth Group was given a new $402.00 price target by New Street Research.
• 10/9/2026 – UnitedHealth Group had its price target lowered by TD Cowen from $430.00 to $402.00. They now have a “hold” rating on the stock.
• 10/8/2026 – UnitedHealth Group was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 9/14/2026 – UnitedHealth Group was downgraded by Zacks Research from “strong-buy” to “hold”.
• 9/2/2026 – UnitedHealth Group had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $512.00 price target on the stock, up from $492.00.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.